Rednex Pharmaceuticals Limited, a active public limited company, was established on 29 December 2020 in Bavla, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304GJ2020PLC119176. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹7.65 Cr.
Employing 49 professional, Its leadership includes Chetanbhai Rugnathbhai Matholiya (Director), Jayeshbhai Amarashibhai Sabava (Director), Aakashbhai Mansukhbhai Gangadiya (Director). Past directors included Akashbhai Mansukhbhai Gangadiya. It holds ₹18.36 Cr open charges and no settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Survey No. 586 And 231, Nr. Skf Bearing, Bavla-Bagodara N. H. -8A, Kerala, Bavla, Gujarat, 382220.
U24304GJ2020PLC119176
119176
29 December 2020
₹11.00 Cr
₹7.65 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rednex Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chetanbhai Rugnathbhai Matholiya | Director | 29 Dec 2020 | Current |
| Jayeshbhai Amarashibhai Sabava | Director | 29 Dec 2020 | Current |
| Aakashbhai Mansukhbhai Gangadiya | Director | 29 Dec 2020 | Current |
| Kashyap Naranbhai Thummar | Director | 16 Sep 2025 | Current |
| Narendrabhai Dineshbhai Khambhaliya | Director | 01 Sep 2025 | Current |
| Rashmi Krunal Lakhani | Director | 01 Sep 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rednex Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 1336.09% increase. The company also saw a substantial improvement in profitability, with a 226.83% increase in profit. The company's net worth Soared by an impressive increase of 31.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Rednex Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹183,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2024 | State Bank Of India | ₹1.23 Cr | Open |
| 09 Sep 2022 | State Bank Of India | ₹17.13 Cr | Open |
Explore comprehensive loan charge details -
Rednex Pharmaceuticals has a workforce of 49 employees as of Mar 19, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rednex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rednex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kashyap Naranbhai Thummar was appointed as a Director was appointed as a Director on 16 Sep 2025 & has been associated with this company since 3 months 1 day . was documented.
Rednex Pharmaceuticals Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was recorded as a recent event.
Rima Amitbhai Dalal was appointed as a Company Secretary was appointed as a Company Secretary on 05 Sep 2025 & has been associated with this company since 3 months 12 days . was recorded as a recent event.
Progress on Akashbhai Mansukhbhai Gangadiya was appointed as a Cfo was appointed as a Cfo on 05 Sep 2025 & has been associated with this company since 3 months 12 days . was documented.
Progress on Narendrabhai Dineshbhai Khambhaliya was appointed as a Director was appointed as a Director on 01 Sep 2025 & has been associated with this company since 3 months 16 days . was documented.
Progress on Rashmi Krunal Lakhani was appointed as a Director was appointed as a Director on 01 Sep 2025 & has been associated with this company since 3 months 16 days . was documented.
The CIN of Rednex Pharmaceuticals Limited is U24304GJ2020PLC119176.
Rednex Pharmaceuticals Limited is headquartered at Survey No. 586 And 231, Nr. Skf Bearing, Bavla-Bagodara N. H. -8A, Kerala, Bavla, Gujarat, 382220.
Rednex Pharmaceuticals Limited was incorporated on 29 December 2020.
The current directors of Rednex Pharmaceuticals Limited are
The primary industry of Rednex Pharmaceuticals Limited is Manufacturing.
Rednex Pharmaceuticals Limited is unlisted.
The authorized capital of Rednex Pharmaceuticals Limited is ₹11.00 Cr, and the paid-up capital is ₹7.65 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX